Myndlift remote neurofeedback scale and clinical delivery

• Myndlift has delivered over 1 million neurofeedback sessions with clinical partners worldwide.¹
• The milestone indicates commercial adoption of EEG-based neurotechnology for remote neurofeedback delivery.^{1 1}

Gardner updates

• Myndlift announced delivery of over 1 million neurofeedback sessions with clinical partners worldwide, indicating commercial adoption of EEG-based neurotechnology at scale. ¹

Weekly enrichment (2026-07-20)

• Myndlift announced on June 26, 2025 (PR Newswire) that it had delivered more than 1,000,000 remote neurofeedback sessions and over 20,000 brain scans in collaboration with clinical partners worldwide.²
• The company crossed the one-million-session mark in 2024 and released a visual “brainwave guide” summarizing insights drawn from the aggregated session data.²
• An analysis of the session data reportedly found that brain activity shifts from slower to faster frequencies with age, which the company frames as potentially supporting memory and cognitive resilience over time.³
• Myndlift was founded in 2014 by co-founders Aziz Kaddan and Anas Abu Mukh, and reports over 10 years of research and product development with 26,000+ members across tens of thousands of users.⁴
• The platform pairs consumer EEG headbands (Muse 2, Muse S, and Muse S Athena) with an optional extra electrode to sample additional scalp locations, feeding a clinician-facing dashboard.⁵
• Care is expert-guided: clinicians run 360-degree assessments (EEG/qEEG, CPT-style attention tests, and 40+ standardized questionnaires) to set baselines and design individualized protocols, then monitor training remotely.⁵
• Neurofeedback is delivered as gamified operant conditioning, where clients stream, play, or watch while real-time audio, visual, and haptic feedback rewards target brainwave states such as increasing alpha and reducing high beta.⁵
• Myndlift markets a qEEG normative database it describes as among the world’s largest, used to generate brain maps benchmarked against population norms (qEEG being an FDA-recognized analysis tool).⁵
• The model targets a scaling bottleneck in clinical neurotech, replacing repeated visits with bulky, costly clinic EEG systems with a remote wearable-plus-app workflow that extends clinician reach for both remote and in-clinic practice.⁵
• Caveats for BCI/neurotech readers: the milestone is a company-reported figure (sessions delivered, not clinical outcomes), the age-versus-frequency claim is an internal data analysis rather than peer-reviewed evidence, and consumer headband EEG offers limited spatial resolution compared with clinical montages.²³

Footnotes

1. https://news.google.com/rss/articles/CBMimwFBVV95cUxPbVNmSHVEZUp5Ty1WVVpXa2tnNTdkenEwczhXczFYMWpfNWJfR0xMRkdmMXhJSkRtSHR0VU1Kdmp0WEhuU1lwQzRMSFZzZjdHR3Y5cVZwMllBOGppaTdlbVJmRDNDWDg1cjkteDgxVkYxOUEyNFcxMjRwb0FoakNGQVJZNmV1Q2hoQXhVLVMtSG4xdmVlX2haaFJzNA?oc=5 ↩ ↩² ↩³ ↩⁴

2. https://www.prnewswire.com/news-releases/myndlift-announces-over-1-million-neurofeedback-sessions-delivered-with-clinical-partners-worldwide-302491341.html ↩ ↩² ↩³

3. https://openminds.com/market-intelligence/bulletins/myndlift-announces-over-1-million-neurofeedback-sessions-delivered-with-clinical-partners-worldwide/ ↩ ↩²

4. https://www.myndlift.com/about-us ↩

5. https://www.myndlift.com/for-mental-health-practitioners ↩ ↩² ↩³ ↩⁴ ↩⁵